Olema Pharmaceuticals, Inc. (OLMA)
25.00
-0.07
(-0.28%)
USD |
NASDAQ |
Dec 31, 16:00
25.00
0.00 (0.00%)
After-Hours: 20:00
Olema Pharmaceuticals Research and Development Expense (TTM): 146.78M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Pfizer Inc. | 10.13B |
| Cidara Therapeutics, Inc. | 131.82M |
| Cogent Biosciences, Inc. | 251.67M |
| Replimune Group, Inc. | 218.21M |
| Alnylam Pharmaceuticals, Inc. | 1.248B |